Prognostic significance of Bax and Fas Ligand in erionite and asbestos induced Turkish malignant pleural mesothelioma

被引:18
|
作者
Kokturk, N
Firat, P
Akay, H
Kadilar, C
Ozturk, C
Zorlu, F
Gungen, Y
Emri, S
机构
[1] Gazi Univ, Sch Med, Dept Pulm Med, Ankara, Turkey
[2] Hacettepe Univ, Sch Med, Dept Pathol, TR-06100 Ankara, Turkey
[3] Ankara Univ, Sch Med, Dept Thorac Surg, TR-06100 Ankara, Turkey
[4] Hacettepe Univ, Sch Med, Dept Stat, TR-06100 Ankara, Turkey
[5] Hacettepe Univ, Sch Med, Dept Radiat Oncol, TR-06100 Ankara, Turkey
[6] Hacettepe Univ, Sch Med, Dept Pulm Med, TR-06100 Ankara, Turkey
关键词
mesothelioma; erionite; asbestos; apoptosis; Bax; Fas Ligand;
D O I
10.1016/j.lungcan.2005.05.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Environmentally exposed erionite is a potent and unique inducer of malignant pleural mesothelioma (MPM) in Central Anatolia in Turkey. Previous studies have shown that erionite induced MPM has different biological behavior than asbestos induced MPM. Although impaired apoptosis has been implicated in tumor biology, the relationship between the type of environmental exposure and apoptosis has not yet been evaluated in MPM. The purpose of this study was to determine the expression of apoptosis regulating proteins and their prognostic significance in erionite and asbestos induced MPM. Thirty-five patients with MPM (16 erionite and 19 asbestos induced), and 17 patients with adenocarcinoma were comparatively evaluated. Expression of Bcl-2, Bax, Fas and Fas Ligand, were assessed by immunohistochemistry. Bcl-2 and Fas did not stain in almost all specimens. The staining extension of Bax was 13.75 +/- 19.27%, 5.89 +/- 14.51% and 7.38 +/- 14.53% for erionite and asbestos induced MPM and adenocarcinoma, respectively (p = 0.566). The staining extension of Fas Ligand was 26.87 +/- 31.87%, 46.10 +/- 37.30% and 26.47 +/- 23.23% for erionite and asbestos induced MPM, and adenocarcinoma, respectively (p = 0.123). Bax negative patients in erionite group had longer survival than Bax positive patients (18 months versus 14 months) (p = 0.06). Fas Ligand positive patients showed statistically better survival than Fas Ligand negative patients in all MPM group (15 months versus 12 months) (p = 0.05). Although all proteins expressed in similar extension in all samples, Bax staining displayed an inverse relation with survival in erionite group. This may implicate a difference in Bax functioning in erionite induced MPM. However, Fas Ligand may be functionally intact to reduce tumor survival. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:189 / 198
页数:10
相关论文
共 50 条
  • [21] Is survivin expression prognostic or predictive in malignant pleural mesothelioma?
    Julija Hmeljak
    Nina Erčulj
    Vita Dolžan
    Jože Pižem
    Izidor Kern
    Viljem Kovač
    Maja Čemažar
    Andrej Cör
    Virchows Archiv, 2013, 462 : 315 - 321
  • [22] Is survivin expression prognostic or predictive in malignant pleural mesothelioma?
    Hmeljak, Julija
    Erculj, Nina
    Dolzan, Vita
    Pizem, Joze
    Kern, Izidor
    Kovac, Viljem
    Cemazar, Maja
    Coer, Andrej
    VIRCHOWS ARCHIV, 2013, 462 (03) : 315 - 321
  • [23] Malignant mesothelioma due to environmental exposure to erionite: follow-up of a Turkish emigrant cohort
    Metintas, M
    Hillerdal, G
    Metintas, S
    EUROPEAN RESPIRATORY JOURNAL, 1999, 13 (03) : 523 - 526
  • [24] The essential role of the mitochondria and reactive oxygen species in cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma
    Stewart, John H., IV
    Tran, Thai-Lan
    Levi, Nicole
    Tsai, Wilson S.
    Schrump, David S.
    Nguyen, Dao M.
    JOURNAL OF SURGICAL RESEARCH, 2007, 141 (01) : 120 - 131
  • [25] Immunohistochemistry as Prognostic Markers for Malignant Pleural Mesothelioma
    Otsuki, Taiichiro
    Maehashi, Nobuko
    Kataoka, Yuki
    Terada, Takayuki
    Kuribayashi, Kozo
    Hirabayashi, Masataka
    Ieki, Ryuji
    Nakano, Takashi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S505 - S505
  • [26] Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos
    Magnani C.
    Agudo A.
    González C.A.
    Andrion A.
    Calleja A.
    Chellini E.
    Dalmasso P.
    Escolar A.
    Hernandez S.
    Ivaldi C.
    Mirabelli D.
    Ramirez J.
    Turuguet D.
    Usel M.
    Terracini B.
    British Journal of Cancer, 2000, 83 (1) : 104 - 111
  • [27] Clinical significance of pleural effusion mesothelin in malignant pleural mesothelioma
    Yamada, Shusai
    Tabata, Chiharu
    Tabata, Rie
    Fukuoka, Kazuya
    Nakano, Takashi
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (10) : 1721 - 1726
  • [28] Asbestos Exposure and Malignant Pleural Mesothelioma: A Systematic Review of Literature
    Santos, Catia
    dos Anjos Dixe, Maria
    Sacadura-Leite, Ema
    Astoul, Philippe
    Sousa-Uva, Antonio
    PORTUGUESE JOURNAL OF PUBLIC HEALTH, 2023, 40 (03) : 188 - 202
  • [29] Screening for Malignant Pleural Mesothelioma and Lung Cancer in Individuals with a History of Asbestos Exposure
    Roberts, Heidi C.
    Patsios, Demetris A.
    Paul, Narinder S.
    dePerrot, Marc
    Teel, Warren
    Boyanati, Hamid
    Shepherd, Frances
    Johnston, Michael R.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (05) : 620 - 628
  • [30] Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases
    Neri, Monica
    Ugolini, Donatella
    Dianzani, Irma
    Gemignani, Federica
    Landi, Stefano
    Cesario, Alfredo
    Magnani, Corrado
    Mutti, Luciano
    Puntoni, Riccardo
    Bonassi, Stefano
    MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2008, 659 (1-2) : 126 - 136